Recent Bills
- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
Committees
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means
BIOMARIN PHARMACEUTICAL INC. is a client on 31 federal lobbying filings, 2023 to 2026, reporting $670K across them. Biotechnology company Based in California.
An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.
Firms
2 it has hired, by filings.
| Registrant | Filings | Reported |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | 16 | — |
| BGR GOVERNMENT AFFAIRS | 15 | $670K |
By year
Filings and what they reported, newest year first.
| Year | Filings | Income | Expenses |
|---|---|---|---|
| 2026 | 6 | $100K | $1.6M |
| 2025 | 8 | $200K | $1.3M |
| 2024 | 8 | $200K | $1.3M |
| 2023 | 9 | $170K | $1.3M |
Issues
The LDA issue codes the filings were filed under.
| Code | Issue | Filings |
|---|---|---|
HCR | Health Issues | 31 |
MMM | Medicare/Medicaid | 16 |
TAR | Tariff (miscellaneous tariff bills) | 8 |
TAX | Taxation/Internal Revenue Code | 4 |
MED | Medical/Disease Research/Clinical Labs | 3 |
BUD | Budget/Appropriations | 2 |
Bills
The bills the filings name, by how many name them.
| Bill | Title | Filings |
|---|---|---|
| H.R. 1262 | Mikaela Naylon Give Kids a Chance Act | 4 |
| H.R. 1509 | Accelerating Kids’ Access to Care Act of 2025 | 4 |
| S. 1637 | MVP Act | 3 |
| S. 752 | Accelerating Kids’ Access to Care Act | 3 |
| S. 932 | Give Kids a Chance Act of 2025 | 2 |
| H.R. 1 | An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | 1 |
| H.R. 5371 | Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E… | 1 |
| H.R. 946 | ORPHAN Cures Act | 1 |
| S. 1862 | ORPHAN Cures Act | 1 |
Lobbyists
Named on the filings.
| Lobbyist | Clients | Filings |
|---|---|---|
| JOHN GREISSING | 1 | 16 |
| KATHRYN LOWELL | 1 | 16 |
| BRENT DEL MONTE | 1 | 15 |
| DANIEL FARMER | 1 | 15 |
| JOEL BAILEY | 1 | 15 |
| JOHN STONE | 1 | 15 |
| REMY MASON | 1 | 15 |
| ROBB WALTON | 1 | 12 |
| DANIEL MAYNE | 1 | 3 |
| JAMES WILLIAMS | 1 | 3 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.
| Client | Registrant | Period | Reported | Posted |
|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2026 second_quarter | $340K | Jul 20, 2026 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2026 second_quarter | $340K | Jul 20, 2026 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2026 second_quarter | $340K | Jul 20, 2026 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2026 second_quarter | $50K | Jul 20, 2026 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2026 first_quarter | $530K | Apr 20, 2026 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2026 first_quarter | $50K | Apr 20, 2026 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2025 fourth_quarter | $390K | Jan 21, 2026 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2025 fourth_quarter | $50K | Jan 20, 2026 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2025 third_quarter | $270K | Oct 20, 2025 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2025 third_quarter | $50K | Oct 20, 2025 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2025 second_quarter | $270K | Jul 21, 2025 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2025 second_quarter | $50K | Jul 21, 2025 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2025 first_quarter | $390K | Apr 21, 2025 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2025 first_quarter | $50K | Apr 21, 2025 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2024 fourth_quarter | $490K | Jan 21, 2025 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2024 fourth_quarter | $50K | Jan 21, 2025 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2024 third_quarter | $240K | Oct 21, 2024 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2024 third_quarter | $50K | Oct 21, 2024 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2024 second_quarter | $180K | Jul 22, 2024 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2024 second_quarter | $50K | Jul 22, 2024 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2024 first_quarter | $410K | Apr 22, 2024 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2024 first_quarter | $50K | Apr 22, 2024 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2023 fourth_quarter | $470K | Jan 23, 2024 |
| BIOMARIN PHARMACEUTICAL INC. | BGR GOVERNMENT AFFAIRS | 2023 fourth_quarter | $50K | Jan 22, 2024 |
| BIOMARIN PHARMACEUTICAL INC. | BIOMARIN PHARMACEUTICAL INC. | 2023 third_quarter | $220K | Oct 20, 2023 |